CDK6 and T-cell acute lymphoblastic leukemia: The cyclin D3-CDK6 complex has been shown to reprogram glycolysis, which ultimately favors the pentose phosphate pathways (PPP) and serine biosynthesis, thereby removing reactive oxygen species in human T cell acute lymphoblastic leukemia (T-ALL) cells58.